ATC level 2
J05Antivirals for systemic use
- Molecules
- 73
- Subgroups
- 1
ATC J05 (Antivirals for systemic use) is a level 2 group in the anatomical therapeutic chemical classification. The catalogue lists 73 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J05.
- AbacavirHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor4 presentations2 brandsJ05AF06
- Abacavir and LamivudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR02
- Abacavir, Dolutegravir and LamivudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR13
- Abacavir, Lamivudine and ZidovudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentationJ05AR04
- AcyclovirOrphanHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor14 presentations2 brandsD06BB03
- Adefovir dipivoxilHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentationJ05AF08
- AtazanavirProtease Inhibitor7 presentations3 brandsJ05AE08
- Atazanavir and CobicistatCytochrome P450 3A Inhibitor1 presentation2 brandsJ05AR15
- Bictegravir, Emtricitabine and Tenofovir alafenamideOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations2 brandsJ05AR20
- BulevirtideOrphan1 presentation2 brandsJ05A
- CabotegravirHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor2 presentations2 brandsJ05AJ04
- CidofovirCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor1 presentationJ05AB12
- Cobicistat and DarunavirJ05AR14
- Cobicistat, Darunavir, Emtricitabine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR22
- Cobicistat, Elvitegravir, Emtricitabine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR
- Cobicistat, Elvitegravir, Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR09
- DarunavirProtease Inhibitor3 presentations3 brandsJ05AE10
- DolutegravirHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor4 presentations2 brandsJ05AX12
- Dolutegravir and LamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR
- Dolutegravir and RilpivirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR21
- DoravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AG06
- Doravirine, Lamivudine and Tenofovir disoproxilHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR
- EfavirenzHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor4 presentations1 brandJ05AG03
- Efavirenz, Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation3 brandsJ05AR06
- Elbasvir and GrazoprevirHepatitis C Virus NS3/4A Protease Inhibitor1 presentation1 brandJ05AP54
- EmtricitabineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations2 brandsJ05AF09
- Emtricitabine and Tenofovir alafenamideOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations3 brandsJ05AR17
- Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8 presentations6 brandsJ05AR03
- Emtricitabine, Rilpivirine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation3 brandsJ05AR19
- Emtricitabine, Rilpivirine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations2 brandsJ05AR08
- Enfuvirtide1 brandJ05AX07
- Ensitrelvir1 presentation2 brandsJ05AE16
- EntecavirHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor5 presentations4 brandsJ05AF10
- EtravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor6 presentations2 brandsJ05AG04
- FamciclovirHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3 presentationsJ05AB09
- FosamprenavirProtease Inhibitor1 presentationJ05AE07
- FoscarnetPyrophosphate Analog2 presentations1 brandJ05AD01
- Fostemsavir1 presentation1 brandJ05AX
- GanciclovirOrphanCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3 presentations1 brandJ05AB06
- Glecaprevir and PibrentasvirOrphanHepatitis C Virus NS3/4A Protease Inhibitor2 presentations2 brandsJ05AP57
- IbalizumabOrphanAntibodies1 presentation1 brandJ05AX23
- LamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor7 presentations4 brandsJ05AF05
- Lamivudine and ZidovudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations1 brandJ05AR01
- Ledipasvir and SofosbuvirOrphanHepatitis C Virus NS5A Inhibitor5 presentations1 brandJ05AP51
- Ledispavir and Sofosbuvir1 brandJ05AX65
- LenacapavirHuman Immunodeficiency Virus 1 Capsid Inhibitor4 presentations4 brandsJ05AX31
- LetermovirOrphanCytomegalovirus DNA Terminase Complex Inhibitor6 presentations1 brandJ05AX18
- Lopinavir and RitonavirProtease Inhibitor5 presentations3 brandsJ05AR10
- MaravirocCCR5 Co-receptor Antagonist5 presentations2 brandsJ05AX09
- MaribavirOrphanCytomegalovirus pUL97 Kinase Inhibitor1 presentation2 brandsJ05AX10
- NelfinavirProtease Inhibitor2 presentations1 brandJ05AE04
- NevirapineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations1 brandJ05AG01
- Nirmatrelvir and Ritonavir1 presentation2 brandsJ05AE30
- OseltamivirNeuraminidase Inhibitor8 presentations3 brandsJ05AH02
- PenciclovirHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor2 presentations1 brandD06BB06
- RaltegravirHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor7 presentations1 brandJ05AJ01
- RemdesivirSARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor1 presentation2 brandsJ05AB16
- RibavirinOrphanNucleoside Analog3 presentationsJ05AB04
- RilpivirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations3 brandsJ05AG05
- RimantadineInfluenza A M2 Protein Inhibitor1 presentationJ05AC02
- RitonavirOrphanCytochrome P450 3A Inhibitor3 presentations3 brandsJ05AE03
- SofosbuvirOrphanHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor4 presentations2 brandsJ05AP08
- Sofosbuvir and VelpatasvirOrphanHepatitis C Virus NS5A Inhibitor5 presentations2 brandsJ05AP55
- Sofosbuvir, Velpatasvir and Voxilaprevi1 brandJ05A
- Sofosbuvir, Velpatasvir and VoxilaprevirHepatitis C Virus NS3/4A Protease Inhibitor1 presentation1 brandJ05AP56
- TecovirimatOrphanOrthopoxvirus VP37 Envelope Wrapping Protein Inhibitor2 presentations2 brandsJ05AX24
- Tenofovir alafenamideHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AF13
- Tenofovir disoproxilOrphanHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor9 presentations4 brandsJ05AF07
- Tipranavir1 brandJ05AE09
- ValacyclovirHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor4 presentations1 brandJ05AB11
- ValganciclovirCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor4 presentations1 brandJ05AB14
- ZanamivirNeuraminidase Inhibitor1 presentation2 brandsJ05AH01
- ZidovudineOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6 presentations1 brandJ05AF01
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.